To delineate the extent of RASAL2 expression alterations in ovarian cancer, we analyzed RASAL2 expression by qRT-PCR in cDNA from 57 patients representing all stages and grades of the disease and 8 normal ovarian epithelium samples (Table 1). This evidence concerns the gene RASAL2 and ovarian cancer.